TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23467813

Group type: EXPERIMENTAL
Intervention: Folic acid plus vitamin B12 supplementation (2 mg of folic acid and 400 μg of vitamin B12 daily for 16 weeks)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Folic acid plus vitamin B12 supplementation
Number of subjects: 140
Study: 20970351

Group type: EXPERIMENTAL
Intervention: tiotropium/formoterol/budenoside (GR1)
Number of subjects: 46

Group type: COMPARATOR
Intervention: tiotropium/formoterol (GR2)
Number of subjects: 46
Study: 19477811

Group type: EXPERIMENTAL
Intervention: Structured meditation program (2 1/2 hours once a week for 7 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 17079524

Group type: EXPERIMENTAL
Intervention: Counterstrain treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 15271741

Group type: EXPERIMENTAL
Intervention: Propofol sedation
Number of subjects: 30

Group type: COMPARATOR
Intervention: No sedation
Number of subjects: 30
Study: 11311835

Group type: EXPERIMENTAL
Intervention: Career counseling program consisting of individual counseling and group sessions using cognitive and behavioral intervention techniques over a 6-month period.
Number of subjects: 171

Group type: COMPARATOR
Intervention: Self-initiated preventive measures among control group dentists (N=35).
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control group dentists who did not undertake preventive action (N=31).
Number of subjects: 171
Study: 9564119

Group type: COMPARATOR
Intervention: Chlorpromazine (CLO) (50 mg/day) + Dexamethasone (DEX) (2 mg/day)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Chlorpromazine (25 mg/day) + Tropisetron (TRO) (5 mg/day)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Chlorpromazine (25 mg/day) + Tropisetron (5 mg/day) + Dexamethasone (2 mg/day)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Tropisetron (TRO) (5 mg/day)
Number of subjects: 160
Study: 8035384

Group type: EXPERIMENTAL
Intervention: Goal-setting subgroup
Number of subjects: 42

Group type: COMPARATOR
Intervention: Pain attention subgroup
Number of subjects: 42
Study: 2721537

Group type: EXPERIMENTAL
Intervention: Co-dergocrine 4 mg/day for 3 weeks
Number of subjects: 0
Study: 5483323

Group type: EXPERIMENTAL
Intervention: Ferrous sulphate administered with tetracycline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ferrous sulphate administered with oxytetracycline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ferrous sulphate administered with methacycline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ferrous sulphate administered with doxycycline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Small doses of iron taken simultaneously with tetracycline
Number of subjects: 0
Study: 31531555

Group type: EXPERIMENTAL
Intervention: Vocal warm-up (VWU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vocal cool-down (VCD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (CG) - vocal rest
Number of subjects: 0
Study: 28637741

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 300

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 300
Study: 25848072

Group type: EXPERIMENTAL
Intervention: Autologous blood-derived products (ABPs)
Number of subjects: 604

Group type: COMPARATOR
Intervention: Corticosteroids (CSs)
Number of subjects: 604

Group type: COMPARATOR
Intervention: Shock-wave (SW) therapy
Number of subjects: 604
Study: 22968670

Group type: EXPERIMENTAL
Intervention: Implant-supported pendulum (ISP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Zygoma anchorage system (ZAS)
Number of subjects: 30
Study: 21351220

Group type: EXPERIMENTAL
Intervention: Carotid stenting
Number of subjects: 310

Group type: COMPARATOR
Intervention: Carotid endarterectomy
Number of subjects: 310
Study: 19487995

Group type: EXPERIMENTAL
Intervention: Deep breathing exercises along with usual treatment for pain
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual treatment for pain (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Deep breathing exercises
Number of subjects: 0
Study: 17185043

Group type: EXPERIMENTAL
Intervention: High-intensity progressive resistance training (PRT), 2 sets of 8 repetitions of 11 exercises, twice a week for 8 weeks, RPE of 15-18
Number of subjects: 0
Study: 15161785

Group type: EXPERIMENTAL
Intervention: Liraglutide 0.75 mg
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Liraglutide 0.45 mg
Number of subjects: 193

Group type: COMPARATOR
Intervention: Glimepiride (1-4 mg)
Number of subjects: 193
Study: 11339099

Group type: EXPERIMENTAL
Intervention: Calcium substitution
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Alfacalcidol
Number of subjects: 220
Study: 9549925

Group type: EXPERIMENTAL
Intervention: PBPCT
Number of subjects: 25
Study: 10150392

Group type: EXPERIMENTAL
Intervention: 10 ml of 0.5% bupivacaine
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 80
Study: 3353525

Group type: EXPERIMENTAL
Intervention: thoracic EA with bupivacaine (0.5%) in combination with a light general anesthesia
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: neuroleptanalgesia (NLA)
Number of subjects: 31

Group type: COMPARATOR
Intervention: halothane anesthesia
Number of subjects: 31
Study: 31563357

Group type: EXPERIMENTAL
Intervention: Low volume (LV) resistance training (mean = 494 kg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High volume (HV) resistance training (mean = 686 kg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Low volume (LV) resistance training
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High volume (HV) resistance training
Number of subjects: 18

Group type: COMPARATOR
Intervention: Low volume (LV) and High volume (HV) resistance training
Number of subjects: 18
Study: 28935285

Group type: EXPERIMENTAL
Intervention: No pelvic examination
Number of subjects: 202

Group type: COMPARATOR
Intervention: Pelvic examination
Number of subjects: 202
Study: 26553190

Group type: EXPERIMENTAL
Intervention: Nebulized 3% hypertonic saline (HS)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Nebulized normal saline (NS)
Number of subjects: 227
Study: 23333254

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation ON
Number of subjects: 16

Group type: COMPARATOR
Intervention: Deep brain stimulation OFF
Number of subjects: 16
Study: 21614414

Group type: EXPERIMENTAL
Intervention: cilostazol 100 mg
Number of subjects: 111

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 111
Study: 18447840

Group type: EXPERIMENTAL
Intervention: nebivolol (5 mg)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: atenolol (50 mg)
Number of subjects: 34
Study: 16685870

Group type: EXPERIMENTAL
Intervention: Automated analysis of T1-weighted MR scans
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Projection eigencoordinates from T1-weighted MR scans
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Best linear model based on 10 eigenvectors + baseline MMSE
Number of subjects: 47
Study: 12718508

Group type: EXPERIMENTAL
Intervention: Albendazole capsules
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ivermectin capsules
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 6
Study: 9928754

Group type: EXPERIMENTAL
Intervention: Verapamil SR/trandolapril 120/0.5 mg o.d. (dose step 1)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Verapamil SR/trandolapril 180/1 mg o.d. (dose step 2)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Verapamil SR/trandolapril 180/2 mg o.d. (dose step 3)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Verapamil SR/trandolapril
Number of subjects: 254
Study: 8601264

Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drugs, sunscreens, topical and intra-lesional corticosteroids, antimalarials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose corticosteroids or immunosuppressants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexamethasone, methylprednisolone, cyclophosphamide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monoclonal antibodies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antihypertensives, cholesterol-lowering drugs, hypoglycemic agents
Number of subjects: 0
Study: 2125646

Group type: EXPERIMENTAL
Intervention: Total Enteral Nutrition (TEN) with a polymeric diet
Number of subjects: 29

Group type: COMPARATOR
Intervention: Total Parenteral Nutrition (TPN)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both groups (TEN and TPN)
Number of subjects: 29
Study: 7471064

Group type: EXPERIMENTAL
Intervention: Pseudoisocytidine (psi ICyd) administered via daily i.v. injection for 5 consecutive days
Number of subjects: 0
Study: 29691618

Group type: EXPERIMENTAL
Intervention: Achilles tendon re-rupture cohort
Number of subjects: 20
Study: 27355507

Group type: EXPERIMENTAL
Intervention: Intervention with workflow modification and adherence/retention package
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 24857827

Group type: EXPERIMENTAL
Intervention: 40 mg fluoxetine daily for 3 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 21083737

Group type: EXPERIMENTAL
Intervention: Ricinus communis solution (RC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite 1%
Number of subjects: 30

Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mucopren Soft (MS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Elite Soft Relining (ES)
Number of subjects: 30
Study: 20404379

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg daily
Number of subjects: 5695

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5695
Study: 18592368

Group type: EXPERIMENTAL
Intervention: Improvisational music therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Play sessions with toys
Number of subjects: 0
Study: 17361519

Group type: EXPERIMENTAL
Intervention: Jinye Baidu Granule (JYBDG), one package three times a day for two weeks
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Jinye Baidu Granule (JYBDG)
Number of subjects: 240
Study: 12901890

Group type: EXPERIMENTAL
Intervention: CAP-Sym patient-based symptom questionnaire
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Process-of-care measures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional outcome measures
Number of subjects: 0
Study: 10964043

Group type: EXPERIMENTAL
Intervention: Neural network approach using genetic algorithms with cascade correlation for diagnosis of delayed gastric emptying from electrogastrograms (EGGs)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Neural network approach using genetic algorithms with cascade correlation
Number of subjects: 152
Study: 8641247

Group type: EXPERIMENTAL
Intervention: Blackcurrant-strawberry nectar (200 ml, twice daily for 4-5 weeks, vitamin C content approximately 70 mg/100 g)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 1727913

Group type: EXPERIMENTAL
Intervention: ICRF‐187 1,000 mg/m2 IV
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control regimen (fluorouracil 500 mg/m2, doxorubicin 50 mg/m2, cyclophosphamide 500 mg/m2 every 21 days IV)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control regimen
Number of subjects: 150
Study: 6463391

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg b.i.d.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Metoprolol 50 mg b.i.d.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Pindolol 5 mg b.i.d.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 30256491

Group type: COMPARATOR
Intervention: 8-week sham acupuncture treatment
Number of subjects: 124
Study: 29716940

Group type: EXPERIMENTAL
Intervention: Bococizumab with statin therapy
Number of subjects: 9738
Study: 26856210

Group type: EXPERIMENTAL
Intervention: Multivessel intervention during index PCI
Number of subjects: 50632

Group type: COMPARATOR
Intervention: Culprit-only intervention during index PCI
Number of subjects: 50632
Study: 24675775

Group type: EXPERIMENTAL
Intervention: Lutein enriched egg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Egg-yolk based beverage
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Zeaxanthin enriched egg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Normal egg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no dietary modification)
Number of subjects: 100
Study: 23003106

Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 8
Study: 20075335

Group type: EXPERIMENTAL
Intervention: Coffee consumption (caffeic acid and ferulic acid)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Water consumption (control)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ferulic acid
Number of subjects: 8
Study: 17765133

Group type: EXPERIMENTAL
Intervention: Mobile Phone-Based Remote Patient Monitoring System
Number of subjects: 33
Study: 15673327

Group type: EXPERIMENTAL
Intervention: Cinacalcet (30 to 180 mg/day)
Number of subjects: 1136
Study: 12055570

Group type: EXPERIMENTAL
Intervention: Endovascular Aneurysm Repair (EAR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional transabdominal surgery
Number of subjects: 0
Study: 9841849

Group type: EXPERIMENTAL
Intervention: Zidovudine plus saquinavir
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Zidovudine and zalcitabine plus saquinavir
Number of subjects: 144

Group type: COMPARATOR
Intervention: Comparison of two-drug vs three-drug combination
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Baseline HIV RNA levels
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Codon 215 mutations
Number of subjects: 144
Study: 7744136

Group type: EXPERIMENTAL
Intervention: Lithotomy position with elevation of the legs
Number of subjects: 10

Group type: COMPARATOR
Intervention: Lithotomy position without elevation of the legs
Number of subjects: 10
Study: 2249070

Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 155

Group type: COMPARATOR
Intervention: Intravenous urography
Number of subjects: 155
Study: 7193307

Group type: EXPERIMENTAL
Intervention: Levodopa administered by mouth
Number of subjects: 12

Group type: COMPARATOR
Intervention: Levodopa administered rectally
Number of subjects: 12
Study: 30761530

Group type: EXPERIMENTAL
Intervention: RM-CPAP group
Number of subjects: 60

Group type: COMPARATOR
Intervention: ZEEP group
Number of subjects: 60

Group type: COMPARATOR
Intervention: RM group
Number of subjects: 60
Study: 29145211

Group type: EXPERIMENTAL
Intervention: S-1 therapy
Number of subjects: 386

Group type: COMPARATOR
Intervention: Taxane
Number of subjects: 386
Study: 26802300

Group type: EXPERIMENTAL
Intervention: Active ankle movement (30 times/min, 1‐7 days after surgery)
Number of subjects: 174
Study: 24103395

Group type: EXPERIMENTAL
Intervention: Dr Atkins' New Diet Revolution
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: The Slim‐Fast Plan
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Weight‐Watchers programme
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Rosemary Conley's Diet and Fitness Plan
Number of subjects: 287

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 287
Study: 22143488

Group type: EXPERIMENTAL
Intervention: Problem-Solving Treatment (adapted for prevention of depression)
Number of subjects: 93
Study: 19766972

Group type: EXPERIMENTAL
Intervention: Many alternatives differentiated on many attributes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Many alternatives differentiated on few attributes
Number of subjects: 0
Study: 17400086

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (EPO) 600 IU/kg once weekly for 4 doses
Number of subjects: 251

Group type: COMPARATOR
Intervention: Preoperative autologous donation (PAD)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (EPO)
Number of subjects: 251
Study: 15877947

Group type: EXPERIMENTAL
Intervention: Comprehensive treatment based on traditional Chinese medical differentiation
Number of subjects: 522

Group type: COMPARATOR
Intervention: General treatment
Number of subjects: 522

Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 522

Group type: COMPARATOR
Intervention: Western medicine treatment
Number of subjects: 522
Study: 12471536

Group type: EXPERIMENTAL
Intervention: Angled swing‐jaw forceps
Number of subjects: 48

Group type: COMPARATOR
Intervention: Large cup disposable forceps
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional reusable upper gastrointestinal forceps
Number of subjects: 48
Study: 10355005

Group type: EXPERIMENTAL
Intervention: Education on decreasing frequent and prolonged feeding with a nursing bottle and other sugar containing foods, daily brushing with 0.4% SnF2 gel, and additional training sessions for one caretaker.
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Monthly topical fluoride treatments with 2% NaF for two children.
Number of subjects: 3
Study: 8633913

Group type: EXPERIMENTAL
Intervention: Protein-sparing therapy group
Number of subjects: 678

Group type: COMPARATOR
Intervention: Control group (conventional therapy)
Number of subjects: 678
Study: 1769603

Group type: EXPERIMENTAL
Intervention: Sublingual nifedipine (used only if diastolic pressure of 110 mmHg or more)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Hydralazine 40 mg per os every 6 hrs, plus sublingual nifedipine (used if diastolic pressure of 110 mmHg or more)
Number of subjects: 38
Study: 6121090

Group type: EXPERIMENTAL
Intervention: Amoxycillin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 30762655

Group type: EXPERIMENTAL
Intervention: ADC of the placenta
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ADC of the fetal brain
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ADC of the fetal lung
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ADC of the fetal kidney
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined ADC of the placenta and fetal organs
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined ADC of the placenta and fetal brain
Number of subjects: 30
Study: 25389072

Group type: EXPERIMENTAL
Intervention: Ischaemic preconditioning (3 cycles of 5-min upper arm cuff inflation to 220 mmHg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No ischaemic preconditioning (no inflation)
Number of subjects: 30
Study: 24661333

Group type: EXPERIMENTAL
Intervention: Degarelix 80 mg
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Degarelix 160 mg
Number of subjects: 385

Group type: COMPARATOR
Intervention: Degarelix 240/80 mg (crossover from leuprolide)
Number of subjects: 385

Group type: COMPARATOR
Intervention: Degarelix 240/160 mg (crossover from leuprolide)
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Degarelix (continuation)
Number of subjects: 385
Study: 22161728

Group type: EXPERIMENTAL
Intervention: Zoledronic acid 5 mg annually for 6 years (Z6, n = 616)
Number of subjects: 1233

Group type: COMPARATOR
Intervention: Placebo (Z3P3, n = 617)
Number of subjects: 1233

Group type: EXPERIMENTAL
Intervention: Zoledronic acid 5 mg annually for 6 years (Z6)
Number of subjects: 1233

Group type: COMPARATOR
Intervention: Placebo (Z3P3)
Number of subjects: 1233
Study: 19786251

Group type: COMPARATOR
Intervention: Placebo arm of 2 prospective randomized studies
Number of subjects: 120
Study: 17996075

Group type: EXPERIMENTAL
Intervention: Iyengar yoga class with home practice
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: exercise class with home practice
Number of subjects: 135

Group type: COMPARATOR
Intervention: wait-list control group
Number of subjects: 135
Study: 15911864

Group type: COMPARATOR
Intervention: Cisplatin
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Cisplatin with topotecan (CT)
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Baseline FACT-G
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Baseline BPI
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Baseline UNI
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Baseline FACT-Cx
Number of subjects: 293
Study: 12198987

Group type: EXPERIMENTAL
Intervention: 15% carbamide peroxide and 0.11% fluoride ion gel
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 100
Study: 11271692

Group type: EXPERIMENTAL
Intervention: Education about the use, storage and nutritional value of fruits and vegetables
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Distribution of farmers' market coupons
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Combination of education and coupons
Number of subjects: 564

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 564

Group type: COMPARATOR
Intervention: Coupons only
Number of subjects: 564
Study: 9755033

Group type: EXPERIMENTAL
Intervention: 50 Hz magnetic field exposure (20 microT, 200 mG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham-exposure
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Square-wave currents
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sinusoidal waveforms
Number of subjects: 30
Study: 7819079

Group type: EXPERIMENTAL
Intervention: Ultrasound imaging
Number of subjects: 47

Group type: COMPARATOR
Intervention: Conventional staging (physical examination, laryngoscopy, CT of thorax and abdomen, bone marrow cytology and histology)
Number of subjects: 47
Study: 3388475

Group type: EXPERIMENTAL
Intervention: DDAVP (300 micrograms)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (Citrated Plasma)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (Heparinized Plasma)
Number of subjects: 0
Study: 8087516

Group type: EXPERIMENTAL
Intervention: CHART regime (Continuous, Hyperfractionated, Accelerated Radiotherapy)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Conventional radiotherapy (60 Gy in 6 weeks)
Number of subjects: 300
Study: 350251

Group type: EXPERIMENTAL
Intervention: Intravenous sodium valproate (800 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral sodium valproate (800 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Comparison with healthy volunteers
Number of subjects: 6
Study: 31619057

Group type: EXPERIMENTAL
Intervention: Intravenous busulfan (BU) pre-transplant
Number of subjects: 13